Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:21:48.815Z.
Calculation as of: 2026-10-06T16:21:48.815Z.
Quote observation: 2026-10-06T16:20:37.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0892caefd8f82b9b6348fc9a5fa5a469bdb14ad1115ffcc50d65bebd568510ae
EARNINGS YIELD
N/A
Journey Medical Corporation
Market Cap
$177.93M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$176.38M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$174.03M
Earnings Yield
N/A
TTM Avg
12.15%
3Y Avg
12.15%
5Y Avg
12.15%
Market Cap
$182.13M
Earnings Yield
92.36%
TTM Avg
50.31%
3Y Avg
28.59%
5Y Avg
28.59%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $177.93M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.38M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $174.03M | N/A | 12.15% | 12.15% | 12.15% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.13M | 92.36% | 50.31% | 28.59% | 28.59% |
| Nkarta, Inc. (NKTX)vs › | $172.78M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $173.18M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $170.85M | N/A | 15.95% | 15.95% | 15.95% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.76M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $185.87M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
